Prevention and Risk Reduction
Lower your risk of cancer with evidence-based prevention strategies. Learn about lifestyle changes, screenings, and risk reduction methods to improve long-term health and well-being.
Self-protecting nanoparticles can enhance colorectal cancer drug delivery
Colorectal cancer (CRC) is one of the most prevalent types of cancer and has a high mortality rate globally. Oral administration of anticancer drugs that pass through the gastrointestinal (GI) tract into the colorectum is a common strategy to deliver drugs in CRC treatment.
Scientists uncover method to halt key driver of prostate and other cancers
Melbourne-based scientists have, for the first time, discovered how to “switch off” a molecule which is one of the top culprits behind prostate cancer, and is also linked to lung and kidney cancers.
This Super Common Habit Could Be Raising Your Risk for Endometrial Cancer
Endometrial cancer isn’t talked about much as much as it should be. It’s the most common cancer of the female reproductive organs in the U.S. and more than 69,000 people in the U.S. are diagnosed with it each year.
Mutations in two gene pairs point to a promising drug target in 5% of adult cancers
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have discovered that about 5% of adult cancers rely heavily on a gene called PELO to survive and that disabling the gene kills those cancer cells. These cancers have mutations in one of two genes, FOCAD or TCC37.
New Nanosystem Offers Precision Targeting and Therapy for Tongue Cancer
Researchers have developed a new nanosystem that provides precision targeting and therapy for tongue cancer, potentially improving treatment outcomes.
Glass of milk a day cuts bowel cancer risk – study – BBC News
Dark leafy greens, bread and non-dairy milks containing calcium were also found to offer protection.
Francis Medical raises $80 million for device that treats prostate cancer – Minneapolis / St. Paul Business Journal
The Maple Grove-based company, spun off from the former NxThera Inc., plans to use proceeds from the round to fund a clinical trial of its Vanquish device in the treatment of prostate cancer.
New breast cancer drug given green light for NHS use
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer.
How nanotechnology is changing cancer treatment
How nanotechnology is changing cancer treatment
